{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:51Z","timestamp":1792807191143,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.seizure.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T14:42:24Z","timestamp":1490193744000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study"],"prefix":"10.1016","volume":"48","author":[{"given":"Harpreet Singh","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sadhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.03.007_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy","volume":"17","author":"Biton","year":"2003","journal-title":"CNS Drugs"},{"issue":"Suppl. 21","key":"10.1016\/j.seizure.2017.03.007_bib0010","first-page":"16","article-title":"Weight gain associated with use of psychotropic medications","volume":"60","author":"Sachs","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.seizure.2017.03.007_bib0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.03.007_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/08830738030180021701","article-title":"Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: result from a post hoc analysis of a randomized, double-blind clinical trial","volume":"18","author":"Biton","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.03.007_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.seizure.2012.05.001","article-title":"Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy","volume":"21","author":"Kanemura","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.03.007_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(03)00091-3","article-title":"Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients","volume":"55","author":"Luef","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.03.007_bib0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.03.007_bib0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isoj\u00e4rvi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0050","unstructured":"2017 revised classification of seizures. Available at: http:\/\/www.epilepsy.com\/article\/2016\/12\/2017-revised-classification-seizures [accessed 11.02.17]."},{"key":"10.1016\/j.seizure.2017.03.007_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic Fatty Liver Disease and Metabolic Syndrome\u2014Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.seizure.2017.03.007_bib0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.seizure.2017.03.007_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4274\/Jcrpe.1127","article-title":"A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents","volume":"5","author":"Singh","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/08830738030180021701","article-title":"Lamotrigine versus valproate monotherapy\u2013associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial","volume":"18","author":"Biton","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0075","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/08830738050200101501","article-title":"Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate","volume":"20","author":"Aydin","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patients during treatment with valproic acid: a retrospective study","volume":"24","author":"Corman","year":"1997","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.seizure.2017.03.007_bib0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0887-8994(02)00505-2","article-title":"Valproic acid-associated weight gain in older children and teens with epilepsy","volume":"28","author":"Elaine","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0090","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1528-1167.2007.01100.x","article-title":"Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study","volume":"48","author":"Prabhakar","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.03.007_bib0095","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.0013-9580.2004.66303.x","article-title":"Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy","volume":"45","author":"El-Khayat","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.03.007_bib0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ejpn.2014.07.004","article-title":"Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective study","volume":"18","author":"Goldberg-stern","year":"2014","journal-title":"J Eur Paedia Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2008.05.006","article-title":"Lack of valproic acid associated weight gain in prepubertal children","volume":"39","author":"Espinosa","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.03.007_bib0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1684\/ecn.2011.0284","article-title":"New adipocytokines levels in children treated with valproic acid","volume":"22","author":"Meral","year":"2011","journal-title":"Eur Cytokine Network"},{"key":"10.1016\/j.seizure.2017.03.007_bib0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","article-title":"Fasting serum insulin and lipid levels in men with epilepsy","volume":"60","author":"Pylv\u00e4nen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.03.007_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1167.2007.01460.x","article-title":"Adiponectin and visfatin concentrations in children treated with valproic acid","volume":"49","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.03.007_bib0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpendmet0196","article-title":"Drug insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications","volume":"2","author":"Brennan","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.seizure.2017.03.007_bib0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","article-title":"Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children","volume":"80","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.03.007_bib0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/en.2005-1030","article-title":"Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid","volume":"147","author":"Qiao","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.seizure.2017.03.007_bib0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.seizure.2017.03.007_bib0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.seizure.2017.03.007_bib0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/epi.13114","article-title":"Valproate modulates glucose metabolism in patients with epilepsy after first exposure","volume":"56","author":"Rakitin","year":"2015","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:47:43Z","timestamp":1761011263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117301814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"alternative-id":["S1059131117301814"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.03.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}